Health Care & Life Sciences » Medical Equipment & Supplies | Accuray Inc.

Accuray Inc. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
369,419.00
379,801.00
398,800.00
383,414.00
404,897.00
Cost of Goods Sold (COGS) incl. D&A
226,619.00
234,399.00
240,087.00
242,073.00
243,202.00
Gross Income
142,800.00
145,402.00
158,713.00
141,341.00
161,695.00
SG&A Expense
160,944.00
164,571.00
157,186.00
151,164.00
165,492.00
EBIT
18,144.00
19,169.00
1,527.00
9,823.00
3,797.00
Unusual Expense
-
-
6,400.00
1,322.00
5,913.00
Non Operating Income/Expense
71.00
2,103.00
835.00
94.00
1,648.00
Interest Expense
14,287.00
16,518.00
17,460.00
17,302.00
14,959.00
Pretax Income
32,360.00
37,790.00
23,168.00
28,541.00
23,021.00
Income Tax
3,088.00
2,419.00
2,336.00
1,038.00
878.00
Consolidated Net Income
35,448.00
40,209.00
25,504.00
29,579.00
23,899.00
Net Income
35,448.00
40,209.00
25,504.00
29,579.00
23,899.00
Net Income After Extraordinaries
35,448.00
40,209.00
25,504.00
29,579.00
23,899.00
Net Income Available to Common
35,448.00
40,209.00
25,504.00
29,579.00
23,899.00
EPS (Basic)
0.47
0.51
0.32
0.36
0.28
Basic Shares Outstanding
75,804.00
78,277.00
80,509.00
82,495.00
84,893.00
EPS (Diluted)
0.47
0.51
0.32
0.36
0.28
Diluted Shares Outstanding
75,804.00
78,277.00
80,509.00
82,495.00
84,893.00
EBITDA
2,420.00
324.00
19,823.00
8,177.00
5,935.00

About Accuray

View Profile
Address
1310 Chesapeake Terrace
Sunnyvale California 94089
United States
Employees -
Website http://www.accuray.com
Updated 07/08/2019
Accuray, Inc. is a radiation oncology company, which engages in the developmen, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.